FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311122959> ?p ?o ?g. }

• W4311122959 abstract "Dual immune checkpoint blockade (ICB) therapy can result in immune-related-adverse events (irAE) such as ICB-hepatitis. An expansion of effector-memory (TEM) CD4 T cells associated with antiviral immunity against herpesviridae was implicated in ICB-hepatitis. Notably, these memory subsets are frequently associated with age. Here, we sought to understand baseline patient, immune and viral biomarkers associated with the development of ICB-hepatitis to identify currently lacking baseline predictors and test if an expansion of TEM or positive serology against herpesviridae can predict ICB-hepatitis.A discovery (n = 39) and validation cohort (n = 67) of patients with advanced melanoma undergoing anti-PD-1&anti-CTLA4 combination therapy (total n = 106) were analyzed for baseline clinical characteristics, occurrence of irAE and oncological outcomes alongside serological status for CMV, EBV and HSV. Immune populations were profiled by high-parametric flow cytometry (n = 29).ICB-hepatitis occurred in 59% of patients within 100 days; 35.9% developed severe (CTCAE 3-4) hepatitis. Incidence of ICB-hepatitis was higher in the younger (< 55y: 85.7%) compared to older (> = 55y: 27.8%) age group (p = 0.0003), occured earlier in younger patients (p < 0.0001). The association of younger age with ICB-Hepatitis was also observed in the validation cohort (p = 0.0486). Incidence of ICB-hepatitis was also associated with additional non-hepatic irAE (p = 0.018), but neither positive IgG serostatus for CMV, EBV or HSV nor TEM subsets despite an association of T cell subsets with age.Younger age more accurately predicts ICB-hepatitis after anti-PD-1&anti-CTLA4 checkpoint therapy at baseline compared to herpes virus serology or TEM subsets. Younger patients should be carefully monitored for the development of ICB-hepatitis." @default.
• W4311122959 created "2022-12-23" @default.
• W4311122959 creator A5009737345 @default.
• W4311122959 creator A5018898724 @default.
• W4311122959 creator A5028357148 @default.
• W4311122959 creator A5036331681 @default.
• W4311122959 creator A5037685249 @default.
• W4311122959 creator A5045839676 @default.
• W4311122959 creator A5053949240 @default.
• W4311122959 creator A5053954796 @default.
• W4311122959 creator A5054826514 @default.
• W4311122959 creator A5059674386 @default.
• W4311122959 date "2022-12-12" @default.
• W4311122959 modified "2023-09-25" @default.
• W4311122959 title "Incidence and severity of immune-related hepatitis after dual checkpoint therapy is linked to younger age independent of herpes virus immunity" @default.
• W4311122959 cites W2166662937 @default.
• W4311122959 cites W2168644961 @default.
• W4311122959 cites W2186476961 @default.
• W4311122959 cites W2519279652 @default.
• W4311122959 cites W2572174216 @default.
• W4311122959 cites W2584361279 @default.
• W4311122959 cites W2613866594 @default.
• W4311122959 cites W2736166064 @default.
• W4311122959 cites W2746991247 @default.
• W4311122959 cites W2753432434 @default.
• W4311122959 cites W2797675588 @default.
• W4311122959 cites W2964133630 @default.
• W4311122959 cites W2981320816 @default.
• W4311122959 cites W2996128776 @default.
• W4311122959 cites W2999042597 @default.
• W4311122959 cites W3037088183 @default.
• W4311122959 cites W3043703771 @default.
• W4311122959 cites W3067523600 @default.
• W4311122959 cites W3121982255 @default.
• W4311122959 cites W3122627530 @default.
• W4311122959 cites W3129833353 @default.
• W4311122959 cites W3135358879 @default.
• W4311122959 cites W4206697524 @default.
• W4311122959 doi "https://doi.org/10.1186/s12967-022-03755-3" @default.
• W4311122959 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36503532" @default.
• W4311122959 hasPublicationYear "2022" @default.
• W4311122959 type Work @default.
• W4311122959 citedByCount "0" @default.
• W4311122959 crossrefType "journal-article" @default.
• W4311122959 hasAuthorship W4311122959A5009737345 @default.
• W4311122959 hasAuthorship W4311122959A5018898724 @default.
• W4311122959 hasAuthorship W4311122959A5028357148 @default.
• W4311122959 hasAuthorship W4311122959A5036331681 @default.
• W4311122959 hasAuthorship W4311122959A5037685249 @default.
• W4311122959 hasAuthorship W4311122959A5045839676 @default.
• W4311122959 hasAuthorship W4311122959A5053949240 @default.
• W4311122959 hasAuthorship W4311122959A5053954796 @default.
• W4311122959 hasAuthorship W4311122959A5054826514 @default.
• W4311122959 hasAuthorship W4311122959A5059674386 @default.
• W4311122959 hasBestOaLocation W43111229591 @default.
• W4311122959 hasConcept C120665830 @default.
• W4311122959 hasConcept C121332964 @default.
• W4311122959 hasConcept C126322002 @default.
• W4311122959 hasConcept C203014093 @default.
• W4311122959 hasConcept C2522874641 @default.
• W4311122959 hasConcept C2776029263 @default.
• W4311122959 hasConcept C2776408679 @default.
• W4311122959 hasConcept C2776455275 @default.
• W4311122959 hasConcept C2777382497 @default.
• W4311122959 hasConcept C2777701055 @default.
• W4311122959 hasConcept C2780030458 @default.
• W4311122959 hasConcept C2780851360 @default.
• W4311122959 hasConcept C61511704 @default.
• W4311122959 hasConcept C71924100 @default.
• W4311122959 hasConcept C8891405 @default.
• W4311122959 hasConceptScore W4311122959C120665830 @default.
• W4311122959 hasConceptScore W4311122959C121332964 @default.
• W4311122959 hasConceptScore W4311122959C126322002 @default.
• W4311122959 hasConceptScore W4311122959C203014093 @default.
• W4311122959 hasConceptScore W4311122959C2522874641 @default.
• W4311122959 hasConceptScore W4311122959C2776029263 @default.
• W4311122959 hasConceptScore W4311122959C2776408679 @default.
• W4311122959 hasConceptScore W4311122959C2776455275 @default.
• W4311122959 hasConceptScore W4311122959C2777382497 @default.
• W4311122959 hasConceptScore W4311122959C2777701055 @default.
• W4311122959 hasConceptScore W4311122959C2780030458 @default.
• W4311122959 hasConceptScore W4311122959C2780851360 @default.
• W4311122959 hasConceptScore W4311122959C61511704 @default.
• W4311122959 hasConceptScore W4311122959C71924100 @default.
• W4311122959 hasConceptScore W4311122959C8891405 @default.
• W4311122959 hasIssue "1" @default.
• W4311122959 hasLocation W43111229591 @default.
• W4311122959 hasLocation W43111229592 @default.
• W4311122959 hasLocation W43111229593 @default.
• W4311122959 hasLocation W43111229594 @default.
• W4311122959 hasLocation W43111229595 @default.
• W4311122959 hasOpenAccess W4311122959 @default.
• W4311122959 hasPrimaryLocation W43111229591 @default.
• W4311122959 hasRelatedWork W1927688270 @default.
• W4311122959 hasRelatedWork W2018512112 @default.
• W4311122959 hasRelatedWork W2152786601 @default.
• W4311122959 hasRelatedWork W2414855532 @default.
• W4311122959 hasRelatedWork W2467770546 @default.
• W4311122959 hasRelatedWork W2956159961 @default.
• W4311122959 hasRelatedWork W3033986845 @default.

• next